AKAM vs EDSA · P/E 27, rev $2.17B vs $64.2M cap
Akamai Technologies Inc (AKAM) versus Edesa Biotech Inc (EDSA) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Edesa Biotech Inc (EDSA) is a biotechnology company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
EDSA does not have a complete income-statement cache yet.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. EDSA currently screens at market cap $64.2M.
Not investment advice. Open the AKAM and EDSA stock pages for the full models.
Not investment advice.